SCHEMBL24251561

SCHEMBL24251561

OCc1cccnc1C1(O)CCOC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 3/20 0.37
PDE10A Q9Y233 3/20 0.37
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
P2RX7 Q99572 1/20 0.31
OPRL1 P41146 2/20 0.30
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30
OPRK1 P41145 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30670274 1.00 PDE2A (0.37) PDE2APDE10AKMT2AMEN1L3MBTL1
SCHEMBL30670248 0.92 PDE2A (0.39) PDE2APDE10AKMT2AMEN1L3MBTL1
SCHEMBL26599210 0.92 PDE2A (0.39) PDE2APDE10AKMT2AMEN1L3MBTL1
SCHEMBL26599261 0.91 KMT2A (0.37) PDE2APDE10AKMT2AMEN1L3MBTL1
SCHEMBL30670230 0.91 KMT2A (0.37) PDE2APDE10AKMT2AMEN1L3MBTL1
SCHEMBL30558736 0.89 PDE2A (0.36) PDE2APDE10A
SCHEMBL25263069 0.89 PDE2A (0.36) PDE2APDE10A
SCHEMBL30670260 0.77 PDE2A (0.34) PDE2APDE10AP2RX7
SCHEMBL26599147 0.77 PDE2A (0.34) PDE2APDE10AP2RX7
SCHEMBL1587985 0.70 MEN1 (0.40) KMT2AMEN1LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339977-A1 SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-10-26 US disclosed
US-20230339977-A1 SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-10-26 US disclosed
CN-114075221-A Substituted heteroaryl compounds, compositions and uses thereof 广东东阳光药业有限公司 2022-02-22 CN disclosed
CN-114075220-A Substituted heteroaryl compounds, compositions and uses thereof 广东东阳光药业有限公司 2022-02-22 CN disclosed
WO-2022033544-A1 SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF 广东东阳光药业有限公司 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339977-A1 SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF TYK2, JAK1, JAK3 PDE2A 3552/4885PDE10A 2458/4885KMT2A 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.